Easy DAO2 index: a novel hemodynamic risk factor for predicting mortality in surgical and critically ill patients Authors: Da-In Eun, Hyeonhoon Lee, Hyung-Chul Lee Published: 2026 ABSTRACT BackgroundMeasurement of the arterial oxygen delivery index (DAO2I) requires substantial medical resources and invasive procedures. We proposed a novel hemodynamic parameter reflecting DAO2I, the Easy DAO2 index (EDI), and examined its association with mortality in non-cardiac surgical and critically ill patients.MethodsWe retrospectively analyzed the data of 95 115 surgical cases from an Asian hospital and 90 420 intensive care unit (ICU) admissions from multicenter hospitals in the United States. EDI was the product of pulse pressure, heart rate, hemoglobin, and peripheral oxygen saturation, divided by body surface area, measured every 5 minutes during anesthesia and hourly for 24 hours post-ICU admission. We assessed the association between 7-day in-hospital mortality and duration of exposure to EDI values below the fifth percentile levels.ResultsIn non-cardiac surgical patients, mortality risk increased with duration of exposure below the low EDI threshold (adjusted odds ratio [aOR] 1.003 per minute; 95% CI [1.000–1.005]). In critically ill patients, mortality risk increased with duration of exposure below the low EDI threshold (aOR 1.014 per hour; 95% CI [1.004–1.023]).ConclusionsLow EDI values were independently associated with mortality in non-cardiac surgical and critically ill patients, suggesting that EDI may be a useful hemodynamic parameter for risk assessment. Introduction Comprehensive hemodynamic monitoring requires flow and pressure parameters to ensure adequate tissue perfusion [1]. The arterial oxygen delivery index (DAO2I) provides crucial information about tissue oxygenation and flow status in surgical and critically ill patients, with inadequate delivery being associated with various adverse outcomes. However, routine monitoring faces significant challenges in clinical practice. The gold standard for measuring cardiac output (CO) involves the use of a pulmonary artery catheter, which risks complications such as arrhythmias, pulmonary artery rupture, and infections [2]. These challenges are particularly pronounced in low-income countries, where the burden of critical illness is high and access to advanced monitoring devices and specially trained healthcare providers is limited. Mean arterial pressure (MAP) has been widely adopted as a hemodynamic parameter, regardless of resource availability in clinical settings. However, blood pressure alone is an unreliable parameter of tissue perfusion. Uncompensated hypotension can disrupt blood flow to end organs and lead to adverse outcomes [3–7]; however, normal blood pressure does not guarantee adequate tissue oxygenation. Hypotension may not indicate tissue hypoxemia if autoregulation is intact [8], and low CO can occur despite normal blood pressure [9]. To address this clinical need for a reliable yet accessible hemodynamic flow monitoring parameter that can be used alongside MAP, we propose the Easy DAO2 index (EDI) as a potential surrogate for DAO2I. Using EDI, DAO2I can be easily estimated even in resource-constrained environments. The EDI is based on the principle that CO is proportional to pulse pressure and heart rate, which can be routinely measured [10]. We hypothesized that lower EDI values would be associated with increased mortality, and that EDI might provide additional prognostic information complementary to conventional blood pressure monitoring. To test this hypothesis, we examined the association of EDI with 7-day in-hospital mortality in two large cohorts: a surgical cohort of 95 115 surgical cases from a single academic hospital in South Korea and a multicenter intensive care unit (ICU) cohort of 90 420 ICU admissions from the United States. Materials and Methods Patient population and data collection This single-center retrospective study was approved by the Institutional Review Board (IRB No. H-2409-038-1569). The requirement for written informed consent was waived due to the retrospective nature of this study. Data were collected from patients who underwent surgery under general anesthesia at Seoul National University Hospital, Seoul, Republic of Korea, from January 2011 to December 2020. We excluded patients < 18 or > 90 years of age, those classified under the American Society of Anesthesiologists Physical Status Classification 6, and those with an anesthesia duration of < 2 hours. Vital signs measured at 1-minute intervals during surgery were extracted from the clinical data warehouse of Seoul National University Hospital. However, we used the 5-minute median of the measured values. In addition, we excluded patients without preoperative hemoglobin (Hb) measurements within 7 days before surgery, those without body surface area data, those with >30% missing intraoperative vital signs, and those who underwent cardiac surgery due to the different meanings of pulse pressure during cardiopulmonary bypass. For critically ill patients, we used data from the electronic ICU (eICU) Collaborative Research Database [11], a multicenter database containing information on 139 367 patients admitted to 208 ICUs across the United States from 2014 to 2015. We considered only the first ICU admission for each patient, excluding admissions of patients discharged within 24 hours. We excluded patients whose vital signs were not recorded within the first 4 hours of admission, those with > 30% missing vital sign data in the first 24 hours, and those without Hb measurements or insufficient data to calculate body surface area. EDI measurements and data preprocessing EDI was designed as a non-invasive surrogate for DAO2I. DAO2I is calculated as follows: where CI is a cardiac index (L/min/m2). Arterial oxygen content (CaO2) is calculated using arterial oxygen saturation (SaO2, %) and partial pressure of oxygen in arterial blood (PaO2, mmHg). Total CaO2, which represents the sum of oxygen bound to Hb and oxygen dissolved in plasma, is calculated as follows: EDI was calculated as the product of pulse pressure (mmHg), heart rate (beats/min), Hb (g/dL), and peripheral oxygen saturation (SpO2, %), multiplied by a unit conversion constant (k) to yield a dimensionless index, divided by body surface area (m2) as follows: EDI approximates oxygen delivery by substituting pulse pressure × heart rate for CO and SpO2 for SaO2, while omitting the dissolved oxygen term, which minimally contributes to total oxygen content. We applied the following exclusion criteria, similar to those used in previous intraoperative studies, to remove physiological artifacts [4,12,13]: (1) MAP < 20 or > 200 mmHg, (2) systolic blood pressure < 10 or > 300 mmHg, (3) diastolic blood pressure < 10 or > 200 mmHg, (4) heart rate < 30 beats/min, or (5) pulse pressure < 10 mmHg. For surgical patients, we considered only Hb values measured within 7 days before the start of anesthesia. If hematocrit (Hct) or Hb levels were measured during anesthesia, these values were carried forward. We analyzed the EDI for surgical patients during anesthesia, calculating it at 5-minute intervals. For critically ill patients, the most recent Hb or Hct was carried forward for EDI calculation. We analyzed the EDI within the first 24 hours following ICU admission, calculating it at 1-hour intervals. For surgical and critically ill patients, we used the formula Hb ≈ Hct/3 to approximate Hb and all available measurements, including those from point-of-care testing. Non-invasive and invasive blood pressure measurements were used in the analysis. The average rate of missing vital signs was 3.6% for 5-minute interval data in surgical patients and 4.8% for hourly data in critically ill patients. For these missing vital signs, we employed forward-fill imputation. Primary outcome We analyzed in-hospital all-cause mortality within 7 days for surgical and critically ill patients. For surgical patients, mortality was assessed from the end of anesthesia. For critically ill patients, mortality was defined as an all-cause death occurring within 7 days of ICU admission. Univariable logistic regression was employed to assess the crude relationship between mortality and the duration of exposure time to below specific EDI or MAP thresholds, as well as potential confounding variables. For surgical patients, we analyzed exposure time during the entire period of general anesthesia. For critically ill patients, we examined this relationship using EDI and MAP exposure time during the first 24 hours following ICU admission. For the primary analysis, we defined the values corresponding to the fifth percentiles as “low EDI” and 65 mmHg as the “low MAP” threshold based on established clinical criteria [4,6]. We then performed multivariable logistic regression analyses to obtain adjusted odds ratios (aORs), controlling for confounding variables, including the Acute Physiology and Chronic Health Evaluation IV score, to adjust for disease severity [14]. Variables with P < 0.2 in the univariable analysis, those with clinical importance, and variance inflation factor < 10 were initially included in the model. Subsequently, a backward elimination procedure was applied to determine the final multivariable model. For surgical patients, the odds ratio (OR) unit was per minute of exposure during general anesthesia, whereas for critically ill patients, it was per hour of exposure during the first 24 hours after ICU admission. To evaluate the discriminative performance of hemodynamic exposure variables for mortality prediction, we performed receiver operating characteristic (ROC) curve analysis. We calculated the area under the receiver operating characteristic curve (AUROC) for univariable models using low EDI and MAP exposures and the multivariable model incorporating confounders. A subgroup analysis was conducted for patients with non-invasive blood pressure (NIBP). A supplementary quadrant analysis classified hemodynamic exposure into four mutually exclusive states based on the defined low thresholds: preserved EDI with preserved MAP (reference), low EDI with preserved MAP, low MAP with preserved EDI, and concurrent low EDI and low MAP. Associations with mortality were assessed, adjusting for the same covariates included in the primary multivariable model. To further evaluate whether EDI provides prognostic value independent of MAP, a direct comparison of mortality risk was performed between patients with concurrent low EDI and MAP and those with preserved EDI and low MAP, using the latter as the reference group and adjusting for the same covariates. Secondary outcome The secondary outcome of this study was the correlation between EDI and the invasively measured DAO2I. The relationship between MAP and DAO2I was also evaluated for comparison. Since the invasively measured DAO2I requires CO measurement, we analyzed data from patients with pulmonary artery catheters using continuous thermodilution methods. Given the inherent measurement delay in continuous thermodilution, we only included measurements where the CO changed by < 10% within 20 minutes before and after each time point. Per-patient Spearman’s rank correlation coefficient was calculated between DAO2I and EDI and between DAO2I and MAP. We included patients with ≥ 10 measurement pairs in the analysis. Statistical analysis Statistical comparisons were performed using independent t-tests or Mann–Whitney U tests for continuous variables, while categorical variables were analyzed with chi-square tests. For primary outcome analysis, the significance of individual coefficients was tested using the Wald test, and the overall model fit was assessed using the likelihood ratio test. For secondary outcome analysis, Spearman’s rank correlation coefficients were calculated and compared using the Wilcoxon signed-rank test. To quantify the magnitude of the difference, we calculated the mean difference and effect size using Cohen’s d for paired samples. All statistical analyses were performed using Python version 3.10.9 with SciPy package version 1.14.1 and Statsmodels package version 0.14.3 [15]. P < 0.05 was considered statistically significant for all analyses. Results Overall, the data of 95 115 surgical cases under general anesthesia and 90 420 ICU admissions were analyzed in this study (Fig. 1). Tables 1 and 2 show the baseline characteristics of surgical and critically ill patients, respectively. Among surgical patients, we observed 200 cases of 7-day in-hospital all-cause mortality. Among critically ill patients, we observed 3552 cases of 7-day in-hospital all-cause mortality. Mortality prediction in surgical patients Univariable analysis identified clinically significant predictors and hemodynamic exposures associated with mortality in surgical patients, as presented in Table 3. Among clinical variables, age, emergency operation status, ischemic heart disease, cerebrovascular accident, chronic kidney disease, hematologic malignancy, and neurosurgery were associated with increased mortality. Anesthesia duration was included in the analysis to control for differential exposure opportunities to low hemodynamic thresholds. In the univariable analysis, mortality risk increased with each additional minute of exposure duration below the low EDI (13.4 × 105) and low MAP thresholds. After adjusting for clinical confounders including comorbidities and surgical departments in non-cardiac surgical patients, the aOR per minute of exposure below the low EDI threshold was 1.003 ((95% CI [1.000–1.005], P = 0.042). The aOR per minute of exposure below the low MAP threshold was 1.010 (95% CI [1.008–1.012], P < 0.001). In the subgroup analysis for patients with NIBP only (n = 39 693), 7-day mortality was observed in 26 patients (0.07%) (Supplementary Table 1). In the quadrant analysis, the concurrent presence of low EDI and MAP was associated with the highest mortality risk, with an aOR of 1.012 (95% CI [1.008–1.015], P < 0.001) (Supplementary Table 2). Within the low MAP subgroup, patients with concurrent low EDI had significantly higher mortality compared to those with preserved EDI, with an aOR of 1.46 (95% CI [1.09–1.94], P = 0.011) (Supplementary Table 3). In the ROC curve analysis, low EDI and MAP exposure durations showed AUROCs of 0.581 and 0.773, respectively. The multivariable model showed an AUROC of 0.882 for predicting mortality. Mortality prediction in critically ill patients In the univariable analysis, mortality risk increased with each additional hour of exposure duration below the low EDI (12.0 × 105) and low MAP thresholds (Table 4). After adjusting for clinical confounders in critically ill patients, the aOR per hour of exposure below the low EDI threshold was 1.014 (95% CI [1.004–1.023], P = 0.004). The aOR per hour of exposure below the low MAP threshold was 1.038 (95% CI [1.032–1.044], P < 0.001). In the subgroup analysis for patients with NIBP only (n = 62 269), 1598 deaths were observed (Supplementary Table 1). In the quadrant analysis, the concurrent presence of low EDI and MAP was associated with the highest mortality risk, with an aOR of 1.072 (95% CI [1.052–1.092], P < 0.001) (Supplementary Table 2). Within the low MAP subgroup, patients with concurrent low EDI had significantly higher mortality compared to those with preserved EDI, with an aOR of 1.42 (95% CI [1.29–1.57], P < 0.001) (Supplementary Table 3). In the ROC curve analysis, low EDI and MAP exposure durations showed AUROCs of 0.529 and 0.620, respectively. The multivariable model showed an AUROC of 0.825 for predicting mortality. Correlation analysis The correlation analysis between EDI and DAO2I included 86 surgical patients (Supplementary Table 4). EDI was moderately positively correlated with DAO2I, with a median (Q1, Q3) per-patient Spearman’s rank correlation coefficient of 0.62 (0.40, 0.77). Conversely, the association between MAP and DAO2I was weaker, yielding a median correlation of 0.19 (−0.11, 0.44) (Fig. 2). Compared to MAP, EDI was significantly more strongly correlated with DAO2I, with a mean difference in Spearman’s rank correlation coefficients of 0.38 and a large effect size (Cohen’s d = 0.93, P < 0.001). Supplementary Figs. 1 and 2 show the overall scatter plot of DAO2I vs. EDI across all measurements and representative individual patient scatter plots, including examples from patients with the highest and lowest correlation coefficients, respectively. Discussion In this study, we introduced EDI as a novel hemodynamic monitoring parameter and observed that EDI and MAP were independently associated with mortality in non-cardiac surgical and critically ill patients. In our primary analysis, prolonged exposure below the low EDI threshold was associated with increased mortality risk. In our secondary analysis, compared to MAP, EDI was moderately but significantly strongly correlated with invasively measured DAO2I (median r = 0.62 vs. 0.19), supporting its potential as a monitoring tool for oxygen delivery assessment. In resource-limited settings, EDI can serve as an effective indicator in several ways: it can be calculated using readily available clinical parameters without any patented algorithms, requires no additional equipment beyond standard hospital monitoring, and does not necessitate specialized training or skills for implementation. The importance of oxygen delivery in surgical and critically ill patients has been recognized for a long time [16–18]. However, measuring DAO2I requires pulmonary artery catheter insertion, which is only feasible in a limited patient population [19], preventing large-scale cohort studies on the relationships between oxygen delivery and mortality. In this context, our findings showed that prolonged exposure to low EDI values was associated with increased mortality in surgical and critically ill patients. These findings align with previous studies showing adverse outcomes with inadequate oxygen delivery [20–22]. In our multivariable analysis, low EDI and MAP exposures were independently associated with mortality when analyzed together. This finding suggests that flow-related (EDI) and pressure-related (MAP) parameters may provide complementary prognostic information in hemodynamic monitoring. These independent associations remained significant after adjustment for surgical department, comorbidities, and disease severity, with these clinical factors explaining the sex differences observed in the univariable analysis. Furthermore, within the low MAP subgroup, concurrent low EDI was independently associated with significantly higher mortality than preserved EDI in the cohorts, suggesting that EDI may offer incremental prognostic information even in the setting of established hemodynamic compromise. Given that normal blood pressure alone does not guarantee adequate organ perfusion [8,23] and prior studies have demonstrated the particularly high risk associated with concurrent hypotension and hypoperfusion, concurrent monitoring of EDI and MAP may contribute to tissue perfusion risk assessment [24], with EDI potentially providing additional information that blood pressure monitoring alone may not capture. Strengths of this study include its large sample size, diverse populations, and novel parameter integration; however, this study has some limitations. First, as a retrospective observational study involving surgical and critically ill patient cohorts, our findings showed associations between EDI exposure and mortality outcomes; however, causality could not be established. The retrospective design inherently limits our ability to control for all possible confounding variables, including unmeasured patient characteristics, treatment decisions, and temporal changes in care practices. Second, the 24-hour observation period for ICU patients may not have captured full clinical complexity, and discontinuous Hb measurements could affect EDI accuracy. Third, our analysis focused on patients with adequate vital sign monitoring and surgical patients with anesthesia duration of ≥ 2 hours, which may have introduced selection bias toward more complex cases requiring sustained monitoring; thereby potentially limiting generalizability to shorter or less intensive procedures. Fourth, the non-significant association between low EDI and mortality in the NIBP only subgroup may partly reflect the characteristics of this population, which is more likely to undergo lower-acuity procedures with inherently lower baseline mortality risk. Fifth, the use of point-of-care devices with varying accuracy, combined with forward-fill imputation for missing Hb values, may have introduced bias in EDI, especially during active bleeding, massive transfusion, or significant fluid shifts. EDI assumes that pulse pressure correlates with stroke volume; however, this relationship may be compromised in patients with altered arterial compliance, such as those receiving vasoactive medications. Finally, the single-center nature of the surgical cohort may limit generalizability. Our correlation analysis included only 86 high-risk surgical patients with pulmonary artery catheters, representing a small number of critically ill surgical cases. This limited sample size and selective patient population, those requiring invasive CO monitoring, may not be representative of the broader surgical population, potentially affecting the generalizability of the observed moderate correlation between EDI and DAO2I. Future studies should examine oxygen demand, longer observation periods, and continuous Hb monitoring, and employ multicenter designs. Future prospective interventional studies should determine optimal EDI targets across different populations and evaluate EDI-guided hemodynamic management. In conclusion, EDI was independently associated with mortality in both surgical and critically ill patients, which may support its potential role as a hemodynamic parameter for risk assessment. Our findings suggest that EDI could offer additional prognostic information alongside conventional blood pressure monitoring. Although further validation is warranted, EDI, derived from readily available clinical parameters, may help address an important gap in hemodynamic monitoring across healthcare settings with varying resource levels.